CTOs on the Move

Biofire Diagnostics

www.biofiredx.com

 
With more than 25 years of molecular experience, BioFire Diagnostics, LLC sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing. As BioMérieux`s Global Center of Excellence for Molecular Diagnostics, no other company has FDA-cleared and CE-IVD marked assays for more pathogens. BioFire Diagnostics has produced the easiest, fastest, and most comprehensive multiplex PCR testing available: the BioFire® FilmArray® System.
  • Number of Employees: 1K-5K
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

ECI MEDICAL TECHNOLOGIES

ECI MEDICAL TECHNOLOGIES INC. is a Bridgewater, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FastHealth Corporation

FastHealth Corporation is a Tuscaloosa, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alpha-Tec Systems Inc

At Alpha-Tec Systems we believe that patient well being, treatment cost, and healthcare as a whole can all be improved by innovation in the clinical laboratory. The handling and preparation of the patient specimen is one of the most important steps in

Pathology Sciences Med Group

Pathology Sciences Med Group is a Chico, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nuvectra

Nuvectra™ is a neuromodulation company committed to helping physicians improve the lives of people with chronic conditions through our medical devices. At Nuvectra, we focus not only on what our devices do, but also on reducing their complexity for clinicians and patients. We are committed to developing products with intelligent innovations and technologies that provide improved outcomes and long-term solutions for our customers. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder and deep brain stimulation (DBS) for the treatment of Parkinson`s Disease. NeuroNexus, a subsidiary owned by Nuvectra, designs, manufactures, and markets leading-edge neural-interface technologies for the neuroscience clinical research market.